VISCERAL ANGIOSARCOMA

Clinical trials for VISCERAL ANGIOSARCOMA explained in plain language.

Never miss a new study

Get alerted when new VISCERAL ANGIOSARCOMA trials appear

Sign up with your email to follow new studies for VISCERAL ANGIOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New combo therapies target Tough-to-Treat angiosarcoma

Disease control Ongoing

This study is testing two different drug combinations for adults with angiosarcoma, a rare and aggressive cancer. For patients who haven't had a specific type of chemo, it compares standard chemo (paclitaxel) alone to that chemo plus an immunotherapy drug (nivolumab). For patient…

Matched conditions: VISCERAL ANGIOSARCOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

VISCERAL ANGIOSARCOMA

Get alerted when new VISCERAL ANGIOSARCOMA trials appear

New combo therapies target Tough-to-Treat angiosarcoma